Learning Objectives
- Describe influenza transmission and mutation dynamics (antigenic shift vs. drift).
- Become familiar with the process of influenza vaccine development and ongoing influenza vaccine research.
- Describe the status of the current HPAI H5N1 outbreak, including the epidemiology of animal outbreaks and human infections. Describe testing options for HPAI H5N1.
This webinar is free to 黑料正能量members and non-members.
The recording will become available within 1 week following the live webinar.
Speakers
News and Views on the H5N1 Situation
Stacey Schultz-Cherry, Ph.D.Department of Host-Microbe Interactions, member
Department of Infectious Diseases, professor
Co-Director, Center for Excellence in Influenza Research and Response
Co-Director, Collaborative Influenza Vaccine Innovation Center
St. Jude Children’s Research Hospital
Current Avian Influenza H5N1 Outbreak in the United States
Nina Gao, Ph.D., D(ABMM)Senior Specialist, Microbial Sciences
California Department of Public Health
Audience
All are welcome to attend, however this webinar is specific to microbiologists, researchers and clinicians.Level of Instruction
Intermediate.Supplemental Materials
Download 黑料正能量and APHL's jointly developed FAQ document for clinical laboratories on testing of Highly Pathogenic Avian Influenza A(H5N1) (HPAI H5N1).Continuing Education (CE) Credit
To make this webinar free to all, no CE credit will be provided.Questions? Contact Nicole Jackson, clinmicro@asmusa.org.
Please email 黑料正能量if you require closed captioning.